Cargando…

Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility

SIMPLE SUMMARY: Nucleocapsid protein is one of the essential proteins for viral replication including the coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19) pneumonia leading to the ongoing pandemic. Whereas this protein has emerged as a potential drug target, its physicochemic...

Descripción completa

Detalles Bibliográficos
Autor principal: Matsuo, Tatsuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224284/
https://www.ncbi.nlm.nih.gov/pubmed/34064163
http://dx.doi.org/10.3390/biology10060454
_version_ 1783711854908932096
author Matsuo, Tatsuhito
author_facet Matsuo, Tatsuhito
author_sort Matsuo, Tatsuhito
collection PubMed
description SIMPLE SUMMARY: Nucleocapsid protein is one of the essential proteins for viral replication including the coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19) pneumonia leading to the ongoing pandemic. Whereas this protein has emerged as a potential drug target, its physicochemical properties and the molecular mechanism of how this protein is involved in viral replication remain unclear. In this review, structural and dynamical aspects of the SARS-CoV-2 nucleocapsid protein (N(CoV2)), which should play a key role in a new drug development and in the interaction with RNA and other proteins are summarized. The structural feature of N(CoV2) is first described. Next, simulation studies on the interaction between potential drug molecules and N(CoV2) are summarized, which show the importance of molecular flexibility. Then, liquid-liquid phase separation phenomenon involving N(CoV2), which has recently been reported, is described. This phenomenon also suggests the importance of molecular flexibility of N(CoV2). Finally, a promising method using neutron scattering to characterize the structure and structural fluctuation of the droplets, which are formed through this phenomenon, is presented. ABSTRACT: The latest coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19) pneumonia leading to the pandemic, contains 29 proteins. Among them, nucleocapsid protein (N(CoV2)) is one of the abundant proteins and shows multiple functions including packaging the RNA genome during the infection cycle. It has also emerged as a potential drug target. In this review, the current status of the research of N(CoV2) is described in terms of molecular structure and dynamics. N(CoV2) consists of two domains, i.e., the N-terminal domain (NTD) and the C-terminal domain (CTD) with a disordered region between them. Recent simulation studies have identified several potential drugs that can bind to NTD or CTD with high affinity. Moreover, it was shown that the degree of flexibility in the disordered region has a large effect on drug binding rate, suggesting the importance of molecular flexibility for the N(CoV2) function. Molecular flexibility has also been shown to be integral to the formation of droplets, where N(CoV2), RNA and/or other viral proteins gather through liquid-liquid phase separation and considered important for viral replication. Finally, as one of the future research directions, a strategy for obtaining the structural and dynamical information on the proteins contained in droplets is presented.
format Online
Article
Text
id pubmed-8224284
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82242842021-06-25 Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility Matsuo, Tatsuhito Biology (Basel) Review SIMPLE SUMMARY: Nucleocapsid protein is one of the essential proteins for viral replication including the coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19) pneumonia leading to the ongoing pandemic. Whereas this protein has emerged as a potential drug target, its physicochemical properties and the molecular mechanism of how this protein is involved in viral replication remain unclear. In this review, structural and dynamical aspects of the SARS-CoV-2 nucleocapsid protein (N(CoV2)), which should play a key role in a new drug development and in the interaction with RNA and other proteins are summarized. The structural feature of N(CoV2) is first described. Next, simulation studies on the interaction between potential drug molecules and N(CoV2) are summarized, which show the importance of molecular flexibility. Then, liquid-liquid phase separation phenomenon involving N(CoV2), which has recently been reported, is described. This phenomenon also suggests the importance of molecular flexibility of N(CoV2). Finally, a promising method using neutron scattering to characterize the structure and structural fluctuation of the droplets, which are formed through this phenomenon, is presented. ABSTRACT: The latest coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19) pneumonia leading to the pandemic, contains 29 proteins. Among them, nucleocapsid protein (N(CoV2)) is one of the abundant proteins and shows multiple functions including packaging the RNA genome during the infection cycle. It has also emerged as a potential drug target. In this review, the current status of the research of N(CoV2) is described in terms of molecular structure and dynamics. N(CoV2) consists of two domains, i.e., the N-terminal domain (NTD) and the C-terminal domain (CTD) with a disordered region between them. Recent simulation studies have identified several potential drugs that can bind to NTD or CTD with high affinity. Moreover, it was shown that the degree of flexibility in the disordered region has a large effect on drug binding rate, suggesting the importance of molecular flexibility for the N(CoV2) function. Molecular flexibility has also been shown to be integral to the formation of droplets, where N(CoV2), RNA and/or other viral proteins gather through liquid-liquid phase separation and considered important for viral replication. Finally, as one of the future research directions, a strategy for obtaining the structural and dynamical information on the proteins contained in droplets is presented. MDPI 2021-05-21 /pmc/articles/PMC8224284/ /pubmed/34064163 http://dx.doi.org/10.3390/biology10060454 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Matsuo, Tatsuhito
Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
title Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
title_full Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
title_fullStr Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
title_full_unstemmed Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
title_short Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility
title_sort viewing sars-cov-2 nucleocapsid protein in terms of molecular flexibility
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224284/
https://www.ncbi.nlm.nih.gov/pubmed/34064163
http://dx.doi.org/10.3390/biology10060454
work_keys_str_mv AT matsuotatsuhito viewingsarscov2nucleocapsidproteinintermsofmolecularflexibility